Black Seed Oil and Inflammation: What the Research Actually Shows
Black seed oil and inflammation is one of the most-written-about pairings in natural health, and one of the most consistently oversold. You will find dozens of pages telling you that Nigella sativa has been proven to lower inflammatory markers in human trials. What you will rarely find is the awkward detail that the meta-analyses on this question openly contradict one another, and that the largest of them — pooling fifty randomised controlled trials — found no statistically significant effect on any of the four markers most often quoted.
This article sets out what the human evidence genuinely shows, where it disagrees with itself, what the laboratory work does and does not establish, and why we will not put our oil alongside an anti-inflammatory medicine in a comparison table. For the broader picture, see our guide to what black seed oil does and our complete benefits guide.
The Short Answer
- Black seed oil is a food supplement, not a medicine, and not a treatment for any inflammatory condition.
- Thymoquinone's anti-inflammatory behaviour in cell and animal models is well documented and genuinely interesting. That is laboratory pharmacology, not a clinical result.
- The human evidence is contradictory. Some meta-analyses report reductions in CRP and TNF-alpha; the largest — Hallajzadeh and colleagues, pooling 50 randomised trials — reported no significant effect on CRP, TNF-alpha, total antioxidant capacity or malondialdehyde.
- Where the same pooled analysis did find consistent effects was on lipids and blood glucose, not on inflammatory markers.
- Individual trials in rheumatoid arthritis, knee osteoarthritis and asthma have reported improvements, but they are small, short and mostly from a narrow group of research centres.
- We will not compare black seed oil to an NSAID. The comparison is not one a food supplement can responsibly make.
- Sidr & Stone publishes a specific, independently verified figure of 2.67% thymoquinone, tested per batch — a measured number, not a slogan.
Understanding Inflammation: Acute vs Chronic
Not all inflammation is the same, and the distinction matters before any of the evidence below can be read sensibly.
Acute inflammation
Acute inflammation is the body's immediate response to injury or infection — redness, swelling, heat and pain around the affected area. It recruits immune cells, clears damaged tissue and begins repair. This is a healthy and necessary process, and suppressing it aggressively can impair healing.
Chronic inflammation
Chronic inflammation is persistent low-grade inflammatory signalling that continues without a clear ongoing threat. It is not visible or immediately painful, and it is associated in the research literature with a range of long-term conditions — among them type 2 diabetes and insulin resistance, cardiovascular disease, autoimmune conditions such as rheumatoid arthritis, inflammatory skin and bowel conditions, and metabolic syndrome.
It is worth being honest about the language here. "Inflammation" as a wellness concept is far broader and vaguer than the specific biological processes researchers measure. When a trial reports a change in serum C-reactive protein, that is a concrete measurement. When a supplement page promises to "fight inflammation", that is doing something much looser. Keeping the two apart is the first step to reading any of this properly — and it is exactly where most coverage of this topic falls down.
What Thymoquinone Does in Laboratory Models
Thymoquinone is the most-studied compound in Nigella sativa, and the mechanistic literature around it is substantial. Everything in this section is drawn from cell-culture and animal work, and none of it is a statement about what happens in a person who takes a spoonful of oil.
In these models, thymoquinone has been reported to inhibit activation of NF-kappaB, a transcription factor that switches on a large number of inflammatory genes at once; to inhibit COX-2, the enzyme that converts arachidonic acid into pro-inflammatory prostaglandins; to lower production of cytokines including TNF-alpha, IL-1beta and IL-6; to inhibit 5-lipoxygenase, a secondary route for inflammatory eicosanoid production relevant to airway inflammation; and to stabilise mast cells, reducing histamine release. It also behaves as an antioxidant, both scavenging free radicals directly and increasing the activity of the body's own antioxidant enzymes.
That is a coherent and genuinely interesting pharmacological profile. It is also the reason so much clinical research has been attempted. But a compound that inhibits an enzyme in a dish is a reason to run a trial, not the result of one — and as the next section shows, the trials have not delivered what the mechanisms promised.
What the Human Evidence Actually Shows — and Where It Contradicts Itself
This is the section that most articles on this topic get wrong, including an earlier version of this one.
The meta-analyses disagree with each other
There are several pooled analyses of Nigella sativa and inflammatory markers, and they do not agree.
On one side, a 2021 systematic review and meta-analysis by Montazeri and colleagues in the Journal of Food Biochemistry reported significant reductions in serum hs-CRP and TNF-alpha alongside increases in total antioxidant capacity. A 2023 updated meta-analysis by Kavyani and colleagues in Inflammopharmacology, pooling 20 randomised trials, reached broadly similar conclusions.
On the other side sits the largest pooling of the lot. Hallajzadeh and colleagues gathered 50 randomised controlled trials of Nigella sativa and reported the effects on inflammatory and oxidative-stress markers as not statistically significant: CRP (weighted mean difference −3.61, 95% CI −9.23 to 2.01), TNF-alpha (−1.18, 95% CI −3.23 to 0.86), total antioxidant capacity (0.31, 95% CI 0.00 to 0.63) and malondialdehyde (−0.95, 95% CI −2.18 to 0.27). Every one of those confidence intervals crosses, or sits on, the line of no effect.
Notably, the same analysis did find consistent, statistically significant reductions in total cholesterol, triglycerides, LDL cholesterol, fasting glucose and HbA1c. So this is not an analysis that failed to detect anything. It detected metabolic effects and did not detect the inflammatory ones — which is a meaningfully different result from "the study was too small to tell".
How can meta-analyses of the same literature disagree?
Easily, and for reasons worth understanding. Pooled analyses differ in which trials they include, which populations they cover, how they handle wildly different doses and preparations, and how they treat heterogeneity. The underlying trials here are mostly small, mostly short, and drawn disproportionately from a limited number of research groups and countries. Small trials with positive results are also more likely to be published than small trials with null ones, which biases any pooling built on them upwards. When a broader net catches a null result and a narrower net catches a positive one, the broader net is usually telling you something about how fragile the positive finding is.
The honest summary: the claim that black seed oil reliably lowers inflammatory markers in humans is not established. It is contested, and the largest analysis available does not support it.
The individual condition trials
Alongside the pooled work sit a number of individual trials. They are worth reporting accurately, as trial findings rather than as expectations.
In rheumatoid arthritis, a placebo-controlled study by Gheita and Kenawy in 40 women reported reductions in the DAS28 disease-activity score and in morning stiffness after one month of Nigella sativa oil capsules. A separate randomised trial by Hadi and colleagues reported changes in inflammatory cytokines in patients with the same condition. Forty participants is a very small trial, and neither has been replicated at scale.
In knee osteoarthritis, a 2022 double-blind randomised placebo-controlled trial by Huseini and colleagues in 116 adults aged 50–70 reported greater pain reduction on a visual-analogue scale in the treatment arm than in the placebo arm over one month, with parallel changes in WOMAC stiffness and function scores. This is one of the better-powered trials in the field, and osteoarthritis is a wear-related rather than autoimmune condition, so it stands somewhat apart from the arthritis work above.
In asthma, a 2017 randomised double-blind placebo-controlled trial by Koshak and colleagues reported improved Asthma Control Test scores and lower blood eosinophil counts after four weeks. Serum immunoglobulin E did not change significantly over the trial period.
What these have in common is small numbers, short durations and no independent replication at scale. Read individually, each is interesting. Read together with the Hallajzadeh pooling, they are a field that has produced a lot of encouraging small studies and not yet produced a settled answer.
Why We Will Not Compare This to an NSAID
This page used to carry a table setting black seed oil against ibuprofen and naproxen — onset, potency, mechanism, best use, long-term risk. We have removed it, and the reason matters more than the removal.
A comparison table is a claim of equivalence in disguise. Putting two columns side by side tells the reader that these are two options for the same job, differing in speed and strength. They are not. An NSAID is a licensed medicine with a characterised dose, a known effect size, a regulated safety profile and an approved indication. Black seed oil is a food. There is no dose at which the two are alternatives, and building a table implies there is one.
The comparison also cannot be made honestly in either direction. We cannot tell you our oil is gentler than an NSAID, because that implies it does the same job more safely. We cannot tell you it is weaker, because that implies it does the same job less well. It does not do the job at all in the sense the reader would take from a table.
The practical version is simpler. If you are managing an inflammatory condition, the medicines and the plan belong to you and your doctor. A supplement does not enter that decision, and nothing on this page should be read as a reason to change, delay or reduce anything you have been prescribed. If you want to add black seed oil to your diet while managing a condition, tell the person treating you — particularly if you take anticoagulants or immunosuppressants.
What This Means in Practice
Given all of the above, what should a reasonable person do with this information?
First, calibrate expectations downwards. If you are taking black seed oil expecting to feel your inflammation lift, the evidence does not support that expectation, and disappointment is the likely outcome. The trials that did report symptom changes measured them over weeks to months with statistical instruments, not as something participants noticed dramatically.
Second, treat it as a food rather than an intervention. Black seed oil is a nutritionally reasonable oil with a long culinary and traditional history. Taken as part of a diet, it needs no further justification. Taken as a therapy on a schedule, it is being asked to do something it has not been shown to do.
Third, be sceptical of precision. Any source telling you exactly how many weeks until your CRP falls is inventing a timeline the literature does not contain. We used to carry one of those on this page. It is gone.
Fourth, if you want the interventions with the strongest evidence for chronic inflammatory load, they are the well-known and unexciting ones: not smoking, regular physical activity, adequate sleep, a diet with more whole foods and fewer ultra-processed ones, and treatment of the underlying condition where one exists. No supplement outperforms that list.
Safety and Considerations
Black seed oil is well tolerated by most adults at culinary and typical supplemental amounts. The considerations that matter:
- Anticoagulant and antiplatelet medication: thymoquinone has demonstrated anticoagulant activity in research. Speak to your GP if you take warfarin, aspirin, clopidogrel or a DOAC.
- Surgery: discontinue at least two weeks before any scheduled procedure, for the same reason.
- Blood-pressure medication: a possible additive lowering effect — discuss with your prescriber.
- Glucose-lowering medication: the pooled evidence for effects on fasting glucose and HbA1c is stronger than for inflammation, so monitor closely if you take insulin, metformin or a sulfonylurea.
- Immunosuppressants and biologics: if you are on methotrexate, a TNF inhibitor or similar, speak to your rheumatologist before adding anything.
- Pregnancy: avoid supplemental doses. Breastfeeding: limited safety data — consult your GP or midwife.
For the fuller picture, see our guide to black seed oil drug interactions and our side effects and safety guide.
Why Sidr & Stone
An article that has just spent two thousand words explaining that the human evidence is contested is a strange place for a sales pitch, and we are not going to make one. What we will say is narrower: whatever you believe about the research, an oil whose thymoquinone content has never been measured tells you nothing at all.
- Independently verified 2.67% thymoquinone, per batch, by Analytice — an ISO-accredited French laboratory, with a Certificate of Analysis you can see.
- Organically grown Ethiopian highland Nigella sativa, selected after a 36-supplier evaluation.
- Cold-pressed below 40°C, which protects the heat-sensitive thymoquinone.
- Unrefined and unfiltered — a single ingredient, nothing added; natural fine sediment is normal.
- Bottled in matte black UV-protective glass, because thymoquinone is degraded by light as well as by heat.
- Halal certified, with 10% of profits given to charity.
- Fulfilment in the UK, EU, and US.
For a fuller walkthrough of what to look for on a label and how to read a Certificate of Analysis, see our guide to choosing a quality black seed oil. We will not tell you Sidr & Stone is the strongest or the best — that would be the very kind of claim this article has spent its length warning against. What we will say is that our figure is 2.67%, independently verified per batch, and the certificate is there to read.
Frequently Asked Questions
Is black seed oil anti-inflammatory?
Thymoquinone behaves as an anti-inflammatory compound in cell and animal models, which is well documented. Whether that translates into measurable changes in people is contested: some meta-analyses report reductions in CRP and TNF-alpha, while the largest pooling of 50 randomised trials found no significant effect on either. Black seed oil is a food supplement, not a treatment for any inflammatory condition.
Why do different studies give different answers?
Because the underlying trials are small, short, use widely varying doses and preparations, and come disproportionately from a narrow set of research centres. Pooled analyses that include more trials tend to find weaker effects, which is the usual signature of small-study and publication bias in a literature.
Does black seed oil lower CRP or TNF-alpha?
The evidence does not settle this. Hallajzadeh and colleagues pooled 50 randomised trials and reported no statistically significant effect on either marker, with confidence intervals crossing the line of no effect. Other, smaller poolings have reported reductions. We would not tell you it lowers either.
What about the joint pain trials?
Trials in rheumatoid arthritis and knee osteoarthritis have reported improvements in disease-activity and pain scores against placebo. They are small — 40 and 116 participants — short, and unreplicated at scale. They are worth knowing about and are not a basis for expecting a result.
How does this compare with ibuprofen?
It is not a comparison we will make. An NSAID is a licensed medicine with a defined dose and indication; black seed oil is a food. Presenting them as alternatives, in either direction, would misrepresent both. Decisions about anti-inflammatory medication belong with your doctor.
Can black seed oil cure rheumatoid arthritis?
No. Black seed oil is a food supplement, not a medicine, and does not cure rheumatoid arthritis or any other condition. Nothing here is a reason to change or delay prescribed treatment, and anyone on immunosuppressant therapy should speak to their rheumatologist before adding a supplement.
Is black seed oil a medicine?
No. Black seed oil is a food supplement, not a medicine. It has a long traditional history and an interesting body of research around thymoquinone, and can be a worthwhile part of a healthy routine — but it does not cure diseases and is not a substitute for medical care. Be cautious of any black seed oil marketed with specific disease-cure claims.
Final Thoughts
Black seed oil and inflammation is a case where the laboratory evidence is genuinely strong and the human evidence genuinely is not. Thymoquinone does the things the mechanistic papers say it does, in the systems those papers studied. What has not followed is a consistent, replicated demonstration that any of it changes an inflammatory marker in a person — and the largest attempt to pool the trials found that it does not.
That is an uncomfortable conclusion for a company that sells the oil, and it is the accurate one. We would rather publish it than repeat a claim that a reader with access to PubMed can check in five minutes. If the field produces a large, independent, well-powered trial that settles the question either way, this page will be updated to say so.
In the meantime the sensible position is unglamorous: black seed oil is a food supplement with a long history, an interesting compound, and a contested clinical literature. If you want it in your diet, that is a perfectly reasonable choice. If you want it to treat an inflammatory condition, the evidence is not there, and the people treating you are the ones to talk to.
Our cold-pressed Ethiopian black seed oil — independently verified at 2.67% thymoquinone — is available now, with fulfilment in the UK, EU, and US.
Our black seed oil is pressed from organically grown Ethiopian highland Nigella sativa, but it is not certified organic: formal organic certification is hard to obtain in the Ethiopian highlands, so we tell you how the seed is grown rather than claim a certificate we do not hold.
Shop Sidr & Stone Cold-Pressed Ethiopian Black Seed Oil — Verified 2.67% Thymoquinone →
References
1. Hallajzadeh J, Milajerdi A, Kolahdooz F, Amirani E, Mirzaei H, Asemi Z. (2020). Effects of Nigella sativa on glycemic control, lipid profiles, and biomarkers of inflammatory and oxidative stress: A systematic review and meta-analysis of randomized controlled clinical trials. Phytotherapy Research. PMID 32394508.
2. Montazeri RS, Fatahi S, Sohouli MH, et al. (2021). The effect of Nigella sativa on biomarkers of inflammation and oxidative stress: A systematic review and meta-analysis of randomized controlled trials. Journal of Food Biochemistry, 45(4), e13625. View study.
3. Kavyani Z, et al. (2023). The effect of Nigella sativa (black seed) on biomarkers of inflammation and oxidative stress: an updated systematic review and meta-analysis of randomized controlled trials. Inflammopharmacology. View study.
4. Gheita TA, Kenawy SA. (2012). Effectiveness of Nigella sativa oil in the management of rheumatoid arthritis patients: a placebo controlled study. Phytotherapy Research, 26(8), 1246–1248. View study.
5. Hadi V, Kheirouri S, Alizadeh M, Khabbazi A, Hosseini H. (2016). Effects of Nigella sativa oil extract on inflammatory cytokine response and oxidative stress status in patients with rheumatoid arthritis: A randomized, double-blind, placebo-controlled clinical trial. Avicenna Journal of Phytomedicine, 6(1), 34–43. View study.
6. Koshak A, Wei L, Koshak E, et al. (2017). Nigella sativa supplementation improves asthma control and biomarkers: A randomized, double-blind, placebo-controlled trial. Phytotherapy Research, 31(3), 403–409. View study.
7. Huseini HF, Mohtashami R, Sadeghzadeh E, et al. (2022). Efficacy and safety of oral Nigella sativa oil for symptomatic treatment of knee osteoarthritis: A double-blind, randomized, placebo-controlled clinical trial. Complementary Therapies in Clinical Practice, 101666. View study.
8. Darakhshan S, Bidmeshki Pour A, Hosseinzadeh Colagar A, Sisakhtnezhad S. (2015). Thymoquinone and its therapeutic potentials. Pharmacological Research, 95–96, 138–158.
Disclaimer: This article describes what published research on Nigella sativa and inflammation has investigated at the time of writing; research findings may change, and readers should check current sources. Black seed oil is a food supplement, not a medicine, and is not a substitute for medical treatment of any condition. Consult your GP before use if pregnant, breastfeeding, or taking medications — particularly anticoagulants, antihypertensives, glucose-lowering drugs, immunosuppressants or biologics. For any health concern, consult a qualified medical professional.